Cargando…

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma

BACKGROUND: Leukemia inhibitory factor (LIF) exhibits significant tumor-promoting function, while its cognate receptor (LIFR) is considered to act as either a tumor promoter or suppressor. Dysregulation of LIF and LIFR is associated with the initiation, progression and metastasis of multiple cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fang, Wang, Yali, Li, Hongjuan, Li, Li, Yang, Xiaofeng, You, Xiaoyan, Tang, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011451/ https://www.ncbi.nlm.nih.gov/pubmed/36925915 http://dx.doi.org/10.3389/fonc.2023.1118906

Ejemplares similares

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)

A prognostic model and immune regulation analysis of uterine corpus endometrial carcinoma based on cellular senescence
por: Gao, Lulu, et al.
Publicado: (2022)

The Expression of Pyroptosis-Related Gene May Influence the Occurrence, Development, and Prognosis of Uterine Corpus Endometrial Carcinoma
por: Huang, Xiaoling, et al.
Publicado: (2022)

Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation
por: Jin, Yan-Bin, et al.
Publicado: (2023)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
por: Xue, Shen, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma
por: Guo, Chenrui, et al.
Publicado: (2022)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
por: Wei, Sitian, et al.
Publicado: (2022)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
por: Gu, Hongmei, et al.
Publicado: (2022)

Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation
por: Yuan, Yi, et al.
Publicado: (2021)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis
por: Zhang, Zheng, et al.
Publicado: (2021)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma
por: Xie, Bing-fan, et al.
Publicado: (2022)

Identification of LIFR, PIK3R1, and MMP12 as Novel Prognostic Signatures in Gallbladder Cancer Using Network-Based Module Analysis
por: Zhao, Xinyi, et al.
Publicado: (2019)

m(6)A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinoma
por: Fang, Fang, et al.
Publicado: (2022)

The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma
por: Gu, Chunyan, et al.
Publicado: (2022)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

Endoplasmic reticulum stress related IncRNA signature predicts the prognosis and immune response evaluation of uterine corpus endometrial carcinoma
por: Chen, Jun, et al.
Publicado: (2023)

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
por: Tang, Weiwei, et al.
Publicado: (2021)

RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
por: Geng, Rong, et al.
Publicado: (2020)

Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
por: Jia, Yuting, et al.
Publicado: (2023)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role
por: Zhu, Lizhe, et al.
Publicado: (2020)

COVID-19–associated lncRNAs as predictors of survival in uterine corpus endometrial carcinoma: A prognostic model
por: Ding, Yang, et al.
Publicado: (2022)

MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma
por: Chen, Junyu, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
por: Niu, Hongjuan, et al.
Publicado: (2022)

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model
por: Cui, Yun-Qian, et al.
Publicado: (2021)

A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors
por: Mao, Shuai, et al.
Publicado: (2023)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

A Novel Set of WNT Pathway Effectors as a Predictive Marker of Uterine Corpus Endometrial Carcinoma–Study Based on Weighted Co-expression Matrices
por: Kośla, Katarzyna, et al.
Publicado: (2019)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
por: Li, Dong, et al.
Publicado: (2021)

Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2019)

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
por: HUANG, YANGQING, et al.
Publicado: (2023)

Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
por: Yuan, Qingchen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dph59b6nu237snbucbi56d6s1f